Cannabis Science, Inc. announced the company has successfully completed reorganization of its European business to better align with the requirements of its customers, partners, and stakeholders. This move is expected to help improve the efficiency and effectiveness of CBIS' European operations, and provide the necessary infrastructure to manage supply-chain logistics, new product development, and revenue growth. The company's activities, including cultivation, extraction, and manufacturing, will be headquartered in The Netherlands while all former Germany operations have been dissolved.